Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone
MYPI2025002173A0Undetermined Publication Date: 2021-02-27SANTEN PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025002173
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-08-27
- Filing Date
- 2020-08-25
- Publication Date
- 2021-02-27
Abstract
An aqueous ophthalmic composition comprising diquafosol or a salt thereof and polyvinylpyrrolidone. An aqueous ophthalmic composition for prevention or treatment of dry eye, comprising diquafosol sodium at a concentration of 3% (w / v), polyvinylpyrrolidone having a K value of 90, and silver nitrate, wherein the aqueous ophthalmic composition is used so as to be instilled into the eye 2 to 4 times a day in a dose of 1 or 2 drops each time. An aqueous ophthalmic composition for prevention or treatment of dry eye, comprising diquafosol sodium at a concentration of 3% (w / v), polyvinylpyrrolidone, and silver nitrate, the aqueous ophthalmic composition being used so as to be instilled into the eye 2 to 4 times a day in a dose of 1 or 2 drops each time, wherein the aqueous ophthalmic composition has a viscosity at 25C of 3 to 30 mPas.
Need to check novelty before this filing date? Find Prior Art
